+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cell Line Development Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • August 2021
  • Region: Global
  • TechNavio
  • ID: 5454752
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the cell line development market and it is poised to grow by $ 4.39 bn during 2021-2025, progressing at a CAGR of 13.17% during the forecast period. This report on the cell line development market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increased demand for monoclonal antibodies and patent expiration of drugs. In addition, increased demand for monoclonal antibodies is anticipated to boost the growth of the market as well.

The cell line development market analysis includes the product segment and geographic landscape.

The publisher's cell line development market is segmented as below:


By Product

  • Media and reagents
  • Equipment

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW
This study identifies the rise in vaccines production as one of the prime reasons driving the cell line development market growth during the next few years.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report on cell line development market covers the following areas:
  • Cell line development market sizing
  • Cell line development market forecast
  • Cell line development market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cell line development market vendors that include Cobra Biologics Ltd., Danaher Corp., Lonza Group Ltd., Merck KGaA, Molecular Devices LLC, Promega Corp., Sartorius AG, Selexis SA, Thermo Fisher Scientific Inc., and WuXi Biologics (Cayman) Inc. Also, the cell line development market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary
  • Market overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Media and reagents - Market size and forecast 2020-2025
  • Equipment - Market size and forecast 2020-2025
  • Market opportunity by Product
Customer landscape
  • Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Cobra Biologics Ltd.
  • Danaher Corp.
  • Lonza Group Ltd.
  • Merck KGaA
  • Molecular Devices LLC
  • Promega Corp.
  • Sartorius AG
  • Selexis SA
  • Thermo Fisher Scientific Inc.
  • WuXi Biologics (Cayman) Inc.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Product - Market share 2020-2025 (%)
22: Comparison by Product
23: Media and reagents - Market size and forecast 2020-2025 ($ million)
24: Media and reagents - Year-over-year growth 2020-2025 (%)
25: Equipment - Market size and forecast 2020-2025 ($ million)
26: Equipment - Year-over-year growth 2020-2025 (%)
27: Market opportunity by Product
28: Customer landscape
29: Market share By Geographical Landscape 2020-2025 (%)
30: Geographic comparison
31: North America - Market size and forecast 2020-2025 ($ million)
32: North America - Year-over-year growth 2020-2025 (%)
33: Europe - Market size and forecast 2020-2025 ($ million)
34: Europe - Year-over-year growth 2020-2025 (%)
35: Asia - Market size and forecast 2020-2025 ($ million)
36: Asia - Year-over-year growth 2020-2025 (%)
37: ROW - Market size and forecast 2020-2025 ($ million)
38: ROW - Year-over-year growth 2020-2025 (%)
39: Key leading countries
40: Market opportunity By Geographical Landscape ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: Cobra Biologics Ltd. - Overview
48: Cobra Biologics Ltd. - Product and service
49: Cobra Biologics Ltd. - Key offerings
50: Cobra Biologics Ltd. - Key customers
51: Cobra Biologics Ltd. - Segment focus
52: Danaher Corp. - Overview
53: Danaher Corp. - Business segments
54: Danaher Corp. - Key offerings
55: Danaher Corp. - Key customers
56: Danaher Corp. - Segment focus
57: Lonza Group Ltd. - Overview
58: Lonza Group Ltd. - Business segments
59: Lonza Group Ltd. - Key offerings
60: Lonza Group Ltd. - Key customers
61: Lonza Group Ltd. - Segment focus
62: Merck KGaA - Overview
63: Merck KGaA - Business segments
64: Merck KGaA - Key offerings
65: Merck KGaA - Key customers
66: Merck KGaA - Segment focus
67: Molecular Devices LLC - Overview
68: Molecular Devices LLC - Product and service
69: Molecular Devices LLC - Key offerings
70: Molecular Devices LLC - Key customers
71: Molecular Devices LLC - Segment focus
72: Promega Corp. - Overview
73: Promega Corp. - Product and service
74: Promega Corp. - Key offerings
75: Promega Corp. - Key customers
76: Promega Corp. - Segment focus
77: Sartorius AG - Overview
78: Sartorius AG - Business segments
79: Sartorius AG - Key offerings
80: Sartorius AG - Key customers
81: Sartorius AG - Segment focus
82: Selexis SA - Overview
83: Selexis SA - Business segments
84: Selexis SA - Key offerings
85: Selexis SA - Key customers
86: Selexis SA - Segment focus
87: Thermo Fisher Scientific Inc. - Overview
88: Thermo Fisher Scientific Inc. - Business segments
89: Thermo Fisher Scientific Inc. - Key offerings
90: Thermo Fisher Scientific Inc. - Key customers
91: Thermo Fisher Scientific Inc. - Segment focus
92: WuXi Biologics (Cayman) Inc. - Overview
93: WuXi Biologics (Cayman) Inc. - Business segments
94: WuXi Biologics (Cayman) Inc. - Key offerings
95: WuXi Biologics (Cayman) Inc. - Key customers
96: WuXi Biologics (Cayman) Inc. - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations

Executive Summary

The publisher Announces the Publication of its Research Report - Global Cell Line Development Market 2021-2025

The publisher recognizes the following companies as the key players in the global cell line development market: Cobra Biologics Ltd., Danaher Corp., Lonza Group Ltd., Merck KGaA, Molecular Devices LLC, Promega Corp., Sartorius AG, Selexis SA, Thermo Fisher Scientific Inc., and WuXi Biologics (Cayman) Inc.

Commenting on the report, an analyst from the publisher said: 'The latest trend gaining momentum in the market is rise in vaccines production.'

According to the report, one of the major drivers for this market is the increased demand for monoclonal antibodies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Cobra Biologics Ltd.
  • Danaher Corp.
  • Lonza Group Ltd.
  • Merck KGaA
  • Molecular Devices LLC
  • Promega Corp.
  • Sartorius AG
  • Selexis SA
  • Thermo Fisher Scientific Inc.
  • WuXi Biologics (Cayman) Inc.